Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Putnak

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
The American Journal of Tropical Medicine and Hygiene|November 2, 2010
Comparative analysis of full-length genomic sequences of 10 dengue serotype 1 viruses associated with different genotypes, epidemics, and disease severity isolated in Thailand over 22 yearsYuxin Tang, Prinyada Rodpradit, Piyawan Chinnawirotpisan, et al.
Virus Genes|March 14, 2012
Intra-genotypic variation of predominant genotype II strains of dengue type-3 virus isolated during different epidemics in Thailand from 1973 to 2001Aimee Zhang, Piyawan Chinnawirotpisan, Yuxin Tang, et al.
The American Journal of Tropical Medicine and Hygiene|January 27, 2004
Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeysKenneth H Eckels, Doria R Dubois, Robert Putnak, et al.
Vaccine|July 5, 2011
Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titersYvonne Van Gessel, Christoph S Klade, Robert Putnak, et al.
The Journal of Infectious Diseases|May 17, 2006
Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccinationWellington Sun, Ananda Nisalak, Montip Gettayacamin, et al.
Virus Genes|January 15, 2011
Letter to the editor: molecular genotyping of Dengue Virus Types 2 and 4 from the Guatemalan and Honduran Epidemics of 2007 using the envelope glycoprotein geneYuxin Tang, Miguel Quintana, Chunlin Zhang, et al.
The American Journal of Tropical Medicine and Hygiene|October 29, 2009
Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performanceStephen J Thomas, Ananda Nisalak, Kathryn B Anderson, et al.
Vaccine|January 24, 2007
A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitisArthur Lyons, Niranjan Kanesa-thasan, Robert A Kuschner, et al.
Human Vaccines|August 2, 2008
Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adultsWellington Sun, Dennis Cunningham, Steven S Wasserman, et al.
The American Journal of Tropical Medicine and Hygiene|January 27, 2004
Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidatesWellington Sun, Robert Edelman, Niranjan Kanesa-Thasan, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
The American Journal of Tropical Medicine and Hygiene|November 2, 2010
Comparative analysis of full-length genomic sequences of 10 dengue serotype 1 viruses associated with different genotypes, epidemics, and disease severity isolated in Thailand over 22 yearsYuxin Tang, Prinyada Rodpradit, Piyawan Chinnawirotpisan, et al.
Virus Genes|March 14, 2012
Intra-genotypic variation of predominant genotype II strains of dengue type-3 virus isolated during different epidemics in Thailand from 1973 to 2001Aimee Zhang, Piyawan Chinnawirotpisan, Yuxin Tang, et al.
The American Journal of Tropical Medicine and Hygiene|January 27, 2004
Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeysKenneth H Eckels, Doria R Dubois, Robert Putnak, et al.
Vaccine|July 5, 2011
Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titersYvonne Van Gessel, Christoph S Klade, Robert Putnak, et al.
The Journal of Infectious Diseases|May 17, 2006
Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccinationWellington Sun, Ananda Nisalak, Montip Gettayacamin, et al.
Virus Genes|January 15, 2011
Letter to the editor: molecular genotyping of Dengue Virus Types 2 and 4 from the Guatemalan and Honduran Epidemics of 2007 using the envelope glycoprotein geneYuxin Tang, Miguel Quintana, Chunlin Zhang, et al.
The American Journal of Tropical Medicine and Hygiene|October 29, 2009
Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performanceStephen J Thomas, Ananda Nisalak, Kathryn B Anderson, et al.
Vaccine|January 24, 2007
A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitisArthur Lyons, Niranjan Kanesa-thasan, Robert A Kuschner, et al.
Human Vaccines|August 2, 2008
Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adultsWellington Sun, Dennis Cunningham, Steven S Wasserman, et al.
The American Journal of Tropical Medicine and Hygiene|January 27, 2004
Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidatesWellington Sun, Robert Edelman, Niranjan Kanesa-Thasan, et al.
Pageof 4